Insider Buying: Vitalhub (TSE:VHI) Director Acquires C$3,077,200.00 in Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen bought 439,600 shares of the stock in a transaction on Tuesday, March 24th. The stock was purchased at an average price of C$7.00 per share, for a total transaction of C$3,077,200.00. Following the completion of the purchase, the director directly owned 588,300 shares in the company, valued at approximately C$4,118,100. This represents a 295.63% increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Thursday, March 26th, Francis Nelson Shen purchased 50,000 shares of Vitalhub stock. The stock was purchased at an average cost of C$6.99 per share, with a total value of C$349,500.00.

Vitalhub Price Performance

VHI opened at C$6.95 on Monday. The firm has a market capitalization of C$439.46 million, a P/E ratio of 69.50, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65. Vitalhub Corp. has a one year low of C$6.67 and a one year high of C$14.64. The company has a fifty day moving average price of C$8.07 and a 200-day moving average price of C$9.29.

Vitalhub (TSE:VHI) last issued its quarterly earnings data on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. The company had revenue of C$31.39 million for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%. On average, analysts expect that Vitalhub Corp. will post 0.2296467 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. ATB Cormark Capital Markets dropped their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a research report on Tuesday, March 10th. Raymond James Financial decreased their price objective on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 24th. Scotiabank lowered their target price on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Finally, Royal Bank Of Canada dropped their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research report on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of C$13.86.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.